| Primary |
| Renal Transplant |
66.9% |
| Immunosuppression |
8.0% |
| Prophylaxis Against Transplant Rejection |
5.2% |
| Hypertension |
4.5% |
| Prophylaxis |
2.9% |
| Liver Transplant |
2.8% |
| Heart Transplant |
1.8% |
| Systemic Lupus Erythematosus |
1.0% |
| Transplant |
0.9% |
| Lung Transplant |
0.8% |
| Anaemia |
0.6% |
| Complications Of Transplanted Kidney |
0.6% |
| Hypercholesterolaemia |
0.6% |
| Blood Pressure |
0.5% |
| Renal And Pancreas Transplant |
0.5% |
| Cytomegalovirus Infection |
0.5% |
| Depression |
0.5% |
| Pancreas Transplant |
0.5% |
| Renal Failure Chronic |
0.4% |
| Renal Hypertension |
0.4% |
|
| Death |
15.7% |
| Vomiting |
10.8% |
| Weight Decreased |
10.8% |
| Urinary Tract Infection |
8.1% |
| Pyrexia |
7.3% |
| Renal Failure |
5.9% |
| Kidney Transplant Rejection |
5.3% |
| Renal Impairment |
3.9% |
| Leukopenia |
3.5% |
| Renal Failure Acute |
3.5% |
| Diarrhoea |
3.0% |
| Surgery |
3.0% |
| Cerebrovascular Accident |
2.8% |
| Dehydration |
2.6% |
| Pneumonia |
2.6% |
| White Blood Cell Count Decreased |
2.6% |
| Blood Creatinine Increased |
2.4% |
| Transplant Rejection |
2.4% |
| Herpes Zoster |
2.0% |
| Nausea |
2.0% |
|
| Secondary |
| Renal Transplant |
64.8% |
| Immunosuppression |
6.9% |
| Prophylaxis |
6.6% |
| Hypertension |
5.5% |
| Prophylaxis Against Transplant Rejection |
3.6% |
| Product Used For Unknown Indication |
2.7% |
| Drug Use For Unknown Indication |
2.0% |
| Liver Transplant |
1.7% |
| Hypercholesterolaemia |
0.7% |
| Immunosuppressant Drug Therapy |
0.7% |
| Respiratory Rate Increased |
0.6% |
| Diabetes Mellitus |
0.5% |
| Infection |
0.5% |
| Pain |
0.5% |
| Kidney Transplant Rejection |
0.5% |
| Mineral Supplementation |
0.5% |
| Blood Cholesterol Increased |
0.4% |
| Bone Disorder |
0.4% |
| Diuretic Therapy |
0.4% |
| Hypothyroidism |
0.4% |
|
| Pyrexia |
13.1% |
| Urinary Tract Infection |
12.1% |
| Weight Decreased |
11.1% |
| Vomiting |
8.1% |
| Kidney Transplant Rejection |
7.7% |
| Leukopenia |
4.2% |
| Renal Failure |
3.7% |
| Renal Tubular Atrophy |
3.7% |
| Wound Infection Staphylococcal |
3.7% |
| Neutropenia |
3.5% |
| Renal Impairment |
3.5% |
| Sepsis |
3.2% |
| Transplant Rejection |
3.2% |
| Renal Failure Acute |
3.0% |
| Thrombosis |
3.0% |
| White Blood Cell Count Decreased |
3.0% |
| Somnolence |
2.7% |
| Urosepsis |
2.7% |
| Lymphocele |
2.5% |
| Pneumonia |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.6% |
| Renal Transplant |
24.8% |
| Hypertension |
5.5% |
| Prophylaxis Against Transplant Rejection |
5.1% |
| Immunosuppression |
3.5% |
| Prophylaxis |
3.3% |
| Drug Use For Unknown Indication |
3.0% |
| Diabetes Mellitus |
2.6% |
| Nuclear Magnetic Resonance Imaging |
2.4% |
| Crohn's Disease |
1.8% |
| Immunosuppressant Drug Therapy |
1.6% |
| Liver Transplant |
1.6% |
| Pain |
1.4% |
| Renal Failure Chronic |
1.1% |
| Supplementation Therapy |
1.1% |
| Blood Pressure |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Mineral Supplementation |
0.9% |
| Anaemia |
0.9% |
| Depression |
0.9% |
|
| Vomiting |
10.6% |
| Kidney Transplant Rejection |
9.3% |
| Transplant Rejection |
7.6% |
| Urinary Tract Infection |
7.6% |
| Pyrexia |
6.6% |
| Death |
6.3% |
| Renal Failure Acute |
6.0% |
| Weight Decreased |
6.0% |
| Renal Transplant |
4.6% |
| Renal Failure |
4.0% |
| Renal Impairment |
4.0% |
| Toxicity To Various Agents |
4.0% |
| Complications Of Transplanted Kidney |
3.3% |
| Leukopenia |
3.3% |
| Diarrhoea |
3.0% |
| Therapeutic Agent Toxicity |
3.0% |
| Transplant Failure |
3.0% |
| Drug Ineffective |
2.6% |
| Lung Disorder |
2.6% |
| Off Label Use |
2.6% |
|
| Interacting |
| Renal Transplant |
61.5% |
| Prophylaxis |
15.4% |
| Cystinosis |
7.7% |
| Hyperlipidaemia |
7.7% |
| Hypertension |
7.7% |
|
| Drug Interaction |
40.0% |
| Malaise |
20.0% |
| Toxicity To Various Agents |
20.0% |
| Weight Increased |
20.0% |
|
